CausalSentinel

Protein Dossier — DUSP13 (Dual specificity protein phosphatase 13B)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Cough on most days -0.102 0.0337 0.00259 Inverse variance weighted 2 cis NA
Cough on most days -0.102 0.0337 0.00259 Inverse variance weighted 2 trans NA
HDL cholesterol 0.0478 0.016 0.00289 Wald ratio 1 cis NA
Childhood intelligence 0.124 0.0431 0.00393 Wald ratio 1 cis NA
Sodium in urine -0.0161 0.00584 0.00598 Inverse variance weighted 2 cis NA
Sodium in urine -0.0161 0.00584 0.00598 Inverse variance weighted 2 trans NA
Diagnoses - main ICD10: R55 Syncope and collapse -0.209 0.0782 0.0076 Inverse variance weighted 2 cis NA
Diagnoses - main ICD10: R55 Syncope and collapse -0.209 0.0782 0.0076 Inverse variance weighted 2 trans NA
Creatinine (enzymatic) in urine -0.0146 0.00568 0.0102 Inverse variance weighted 2 cis NA
Creatinine (enzymatic) in urine -0.0146 0.00568 0.0102 Inverse variance weighted 2 trans NA
Non-cancer illness code self-reported: emphysema or chronic bronchitis -0.139 0.0593 0.0187 Inverse variance weighted 2 cis NA
Non-cancer illness code self-reported: emphysema or chronic bronchitis -0.139 0.0593 0.0187 Inverse variance weighted 2 trans NA
…and 157 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

No prot-* pQTL GWAS dataset found for this protein (matched by UniProt accession and symbol).

3. GWAS Catalog results — traits with signal at this locus

No GWAS Catalog associations mapped to this gene.

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 47 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
atrial fibrillation 0.732 common-variant locus no MR -> candidate analysis
major depressive disorder 0.683 common-variant locus MR: beta=-0.149, p=0.0372 (cis)
coronary artery disorder 0.625 common-variant locus no MR -> candidate analysis
peripheral arterial disease 0.625 common-variant locus no MR -> candidate analysis
smoking initiation 0.574 common-variant locus no MR -> candidate analysis
insomnia 0.55 common-variant locus no MR -> candidate analysis
diabetes mellitus 0.082 common-variant locus no MR -> candidate analysis
atrial flutter 0.058 common-variant locus no MR -> candidate analysis
type 2 diabetes mellitus 0.047 common-variant locus no MR -> candidate analysis
hypertensive disorder 0.037 common-variant locus no MR -> candidate analysis
coronary atherosclerosis 0.033 common-variant locus no MR -> candidate analysis

Of the 11 rows above, 10 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability not available — no ChEMBL target (undrugged)
gnomAD constraint not available
GWAS Catalog no mapped SNPs
ClinVar no records
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance